Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
J Korean Med Sci. 2018 Feb 5;33(6):e42. doi: 10.3346/jkms.2018.33.e42.
The Korea Central Cancer Registry reported that incidence rates of prostate cancer have not increased continuously. We used recent trends in the incidence of prostate cancer to generate a preliminary report of the Korean population with prostate cancer.
Patients initially diagnosed with prostate cancer by prostate biopsy from 2006 to 2015 at our tertiary center were selected. All patients were categorized according to age (< 65, 65-75, > 75 years), time period (2006-2010 vs. 2011-2015), and risk classification. Patients with insufficient data were excluded from the analysis.
Of 675 patients (median prostate-specific antigen [PSA], 9.09 ng/mL), those with a Gleason score (GS) of 6 (32.3%) comprised the largest proportion in our cohort. The proportion with a GS of 8 increased for those aged 65-75 years, despite the lack of increase in PSA. Treatment patterns changed for those with very low to low risk cancer. The overall survival (OS) rate and the cancer-specific survival (CSS) rate for all patients at 5 years were 87% and 90%, respectively. Patients with a low body mass index (BMI; ≤ 23 kg/m²) had worse median OS and CSS rates.
Significant differences in risk classifications and initial treatments were found between 2006-2010 and 2011-2015. Although PSA did not change, the GS did change. Lower BMI (≤ 23 kg/m²) had worse effects on OS and CSS rates for Korean prostate cancer patients.
韩国中央癌症登记处报告称,前列腺癌的发病率并未持续增加。我们利用前列腺癌发病率的最新趋势,初步报告了韩国前列腺癌患者的情况。
我们选择了 2006 年至 2015 年期间在我们的三级中心通过前列腺活检首次诊断为前列腺癌的患者。所有患者均根据年龄(<65 岁、65-75 岁、>75 岁)、时间段(2006-2010 年与 2011-2015 年)和危险度分类进行分类。未纳入分析的患者数据不足。
在 675 名患者(中位前列腺特异性抗原 [PSA],9.09ng/ml)中,GS 为 6 分(32.3%)的患者构成了我们队列中的最大比例。对于 65-75 岁的患者,尽管 PSA 没有增加,但 GS 为 8 分的比例有所增加。对于低危和中危癌症患者,治疗模式发生了变化。所有患者的 5 年总生存率(OS)和癌症特异性生存率(CSS)分别为 87%和 90%。身体质量指数(BMI;≤23kg/m²)较低的患者中位 OS 和 CSS 率较差。
在 2006-2010 年和 2011-2015 年之间,风险分类和初始治疗存在显著差异。尽管 PSA 没有变化,但 GS 发生了变化。BMI(≤23kg/m²)较低会对韩国前列腺癌患者的 OS 和 CSS 率产生更不利的影响。